TOP2B

Chr 3AD

DNA topoisomerase II beta

Also known as: BILU, TOPIIB, top2beta

This gene encodes DNA topoisomerase II beta, which alters DNA topology by creating transient double-strand breaks to allow DNA strands to pass through each other during transcription and replication, and specifically functions as a key decatenating enzyme important for B-cell differentiation. Mutations cause autosomal dominant B-cell immunodeficiency with distal limb anomalies and urogenital malformations. The gene is highly constrained against loss-of-function variants, indicating that such mutations are likely to be severely deleterious.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.251 OMIM phenotype
Clinical SummaryTOP2B
🧬
Gene-Disease Validity (ClinGen)
B-cell immunodeficiency, distal limb anomalies, and urogenital malformations · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 282 VUS of 600 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.25LOEUF
pLI 1.000
Z-score 6.97
OE 0.15 (0.100.25)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
3.86Z-score
OE missense 0.61 (0.560.66)
474 obs / 777.1 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.15 (0.100.25)
00.351.4
Missense OE0.61 (0.560.66)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 12 / 78.8Missense obs/exp: 474 / 777.1Syn Z: 0.86
DN
0.3991th %ile
GOF
0.2995th %ile
LOF
0.67top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.25
DN1 literature citation

Literature Evidence

DNWe use Saccharomyces cerevisiae, and knockin and knockout murine models, to demonstrate that patient mutations in TOP2B have a dominant negative effect on enzyme function, resulting in defective proliferation, survival of B-2 cells, causing a block in B cell development, and impair humoral function PMID:31409799

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

600 submitted variants in ClinVar

Classification Summary

Pathogenic4
VUS282
Likely Benign267
Benign11
Conflicting2
4
Pathogenic
282
VUS
267
Likely Benign
11
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
4
0
4
Likely Pathogenic
0
0
0
0
0
VUS
22
237
18
5
282
Likely Benign
1
3
149
114
267
Benign
0
0
10
1
11
Conflicting
2
Total23240181120566

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TOP2B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗